Zyn nicotine pouches are FDA-authorized but can pose health risks. A doctor breaks down 7 risks from gum damage to heart effects backed by the latest research.
We don’t have an innovation problem in healthcare—we have an honesty problem. How to fix our broken culture of healthcare innovation.
GLP-1 drugs are fueling a surge in direct-to-consumer medications. But convenience may be replacing coordination—and creating new risks for patients.
The challenge for health systems now is finding an AI partner that can scale across use cases. That is the backdrop for Cleveland Clinic’s partnership with Luminai.
Medicaid funding cuts lead to hospital closures which allows remaining hospitals to raise prices
In this week’s edition of InnovationRx, we look at the first robotic cataract surgeries in humans, the underbelly of marketing compounded GLP-1s, and more.
A lymph node–targeted delivery platform releases antibody therapy only in tumor-like conditions, strengthening immune attack on metastatic cancer.
Should a judge decide a mother’s birth plan? The case of a Florida woman in active labor exposes how post-Dobbs healthcare is eroding patient autonomy.
Medicare insolvency is not inevitable, and it’s important to question why politicians continually present it as if it is.
The right prescription for our healthcare ills is free markets, not more government.